Phase II Study of Sorafenib Combined with Concurrent Hepatic Arterial Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin for Unresectable Hepatocellular Carcinoma with Major Portal Vein Thrombosis

被引:0
作者
Min-Ke He
Ru-Hai Zou
Qi-Jiong Li
Zhong-Guo Zhou
Jing-Xian Shen
Yong-Fa Zhang
Zi-Shan Yu
Li Xu
Ming Shi
机构
[1] Sun Yat-sen University Cancer Center,Department of Hepatobiliary Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine
[2] Sun Yat-sen University Cancer Center,Department of Ultrasonography, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine
[3] Sun Yat-sen University Cancer Center,Department of Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine
[4] Fudan University Shanghai Cancer Center,Department of Liver Surgery
来源
CardioVascular and Interventional Radiology | 2018年 / 41卷
关键词
Hepatocellular carcinoma; Tumor thrombosis; Hepatic arterial infusion chemotherapy (HAIC); Sorafenib; Oxaliplatin; Fluorouracil;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:734 / 743
页数:9
相关论文
共 32 条
[1]  
Kokudo T(2016)Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion J Hepatol 65 938-943
[2]  
Chan SL(2014)International validation of the Chinese university prognostic index for staging of hepatocellular carcinoma: a joint United Kingdom and Hong Kong study Chin J Cancer 33 481-491
[3]  
Bruix J(2011)Management of hepatocellular carcinoma: an update Hepatology 53 1020-1022
[4]  
Sherman M(2012)EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 56 908-943
[5]  
Jeong SW(2013)Practical effect of sorafenib monotherapy on advanced hepatocellular carcinoma and portal vein tumor thrombosis Gut Liver 7 696-703
[6]  
do Song S(2015)A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis J Gastroenterol 50 445-454
[7]  
Zhang Y(2015)Sorafenib with and without transarterial chemoembolization for advanced hepatocellular carcinoma with main portal vein tumor thrombosis: a retrospective analysis Oncologist 20 1417-1424
[8]  
Ikeda M(2016)Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial Ann Oncol 27 2090-2096
[9]  
Ueshima K(2015)Phase I/II study of sorafenib in combination with hepatic arterial infusion chemotherapy using low-dose cisplatin and 5-fluorouracil Liver Cancer 4 263-273
[10]  
Ma SQ(2016)The lack of Raf-1 kinase feedback regulation enhances antiapoptosis in cancer cells Oncogene 36 2014-2022